Mammoth Biosciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 180

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 30

Mammoth Biosciences General Information

Description

Developer of a CRISPR-based detection platform designed to democratize disease detection. The company's platform provides an easy and affordable point-of-need test that allows rapid and simultaneous detection of multiple conditions, enabling healthcare providers, researchers, and biotech professionals to have access to an efficient platform for molecular diagnostics.

Contact Information

Website
www.mammoth.bio
Formerly Known As
Apheleia Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 1000 Marina Boulevard
  • Suite 600
  • Brisbane, CA 94005
  • United States
+1 (650) 000-0000

Mammoth Biosciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mammoth Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 00000 Completed Generating Revenue
7. Later Stage VC (Series D) 09-Sep-2021 00000 00000 00.000 Completed Generating Revenue
6. Later Stage VC (Series C) 19-May-2020 0000 00000 00000 Completed Generating Revenue
5. Early Stage VC (Series B) 30-Jan-2020 0000 000.00 00000 Completed Generating Revenue
4. Early Stage VC (Series A) 30-Jul-2018 0000 000.00 0000 Completed Generating Revenue
3. Accelerator/Incubator 24-Jan-2018 00000 Completed Generating Revenue
2. Accelerator/Incubator 15-May-2017 $120K $120K 0000 Completed Startup
1. Spin-Off 01-Jan-2017 Completed Startup
To view Mammoth Biosciences’s complete valuation and funding history, request access »

Mammoth Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-1 0,000,000 00.000000 00 000.00 000.00 00 000.00 0.000
Series D 00,000,000 00.000000 00 000.00 000.00 00 000.00 0.00
Series C-1 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 13,631,447 $0.000100 8% $2.7 $2.7 1x $2.7 17.06%
Series A 18,051,205 $0.000100 8% $1 $1 1x $1 22.59%
To view Mammoth Biosciences’s complete cap table history, request access »

Mammoth Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a CRISPR-based detection platform designed to democratize disease detection. The company's platform provide
Decision/Risk Analysis
Brisbane, CA
180 As of 2023
00000
00000 00000 00000

000000

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
00000 0000000000 000
Oakland, CA
00 As of 0000
000.00
000000 - 000 000.00

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
00000 0000000000 000
San Francisco, CA
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mammoth Biosciences Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fabric Genomics Venture Capital-Backed Oakland, CA 00 000.00 000000 - 000 000.00
Syapse Venture Capital-Backed San Francisco, CA 000 00000 0000000000 0 00000
e-NIOS Venture Capital-Backed Athens, Greece 00 00000 000000000000 00000
PierianDx Private Equity-Backed Creve Coeur, MO 000 000.00 000000000000 000.00
Phenomic AI Venture Capital-Backed Toronto, Canada 00 00.000 000000 0
To view Mammoth Biosciences’s complete competitors history, request access »

Mammoth Biosciences Patents

Mammoth Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230323406-A1 Effector proteins and methods of use Pending 21-Jan-2022 0000000000 0
US-20230257739-A1 Effector proteins and methods of use Pending 21-Jan-2022 000000000
US-20230068771-A1 Effector proteins and methods of use Active 10-May-2021 0000000000
US-20230203481-A1 Effector proteins and methods of use Pending 10-May-2021 0000000000 0
US-11814620-B2 Effector proteins and methods of use Active 10-May-2021 C12N15/111 00
To view Mammoth Biosciences’s complete patent history, request access »

Mammoth Biosciences Executive Team (12)

Name Title Board Seat Contact Info
Trevor Martin Ph.D Co-Founder, Board Member & Chief Executive Officer
Elaine Sun Chief Operating Officer & Chief Financial Officer
Janice Chen Ph.D Co-Founder, Board Member and Chief Technology Officer
Lucas Harrington Co-Founder, President & Chief Science Officer
Ted Tisch Chief Agility Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Mammoth Biosciences Board Members (8)

Name Representing Role Since
Dean Minor MD Self Advisory Board Member 000 0000
Jeffrey Huber Self Board Member 000 0000
Jennifer Doudna Ph.D Mammoth Biosciences Co-Founder & Chair of Scientific Advisory Board 000 0000
Jeremy Green Redmile Group Board Member 000 0000
Maneesh Jain Ph.D Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Mammoth Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mammoth Biosciences Investors (30)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mission BioCapital Venture Capital Minority 000 0000 000000 0
Senator Investment Group Hedge Fund Minority 000 0000 000000 0
Sixth Street Partners Growth/Expansion Minority 000 0000 000000 0
SV Angel Angel Group Minority 000 0000 000000 0
Vectr Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 30 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »